[go: up one dir, main page]

JP2004530731A5 - - Google Patents

Download PDF

Info

Publication number
JP2004530731A5
JP2004530731A5 JP2003510034A JP2003510034A JP2004530731A5 JP 2004530731 A5 JP2004530731 A5 JP 2004530731A5 JP 2003510034 A JP2003510034 A JP 2003510034A JP 2003510034 A JP2003510034 A JP 2003510034A JP 2004530731 A5 JP2004530731 A5 JP 2004530731A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003510034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004530731A (ja
Filing date
Publication date
Priority claimed from DE10134775A external-priority patent/DE10134775A1/de
Application filed filed Critical
Publication of JP2004530731A publication Critical patent/JP2004530731A/ja
Publication of JP2004530731A5 publication Critical patent/JP2004530731A5/ja
Pending legal-status Critical Current

Links

JP2003510034A 2001-07-06 2002-07-06 １−アルキル−２−アリール−ベンズイミダゾール誘導体、医薬製剤の製造のためへのそれらの使用、及びそれらの誘導体を含む医薬製剤 Pending JP2004530731A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10134775A DE10134775A1 (de) 2001-07-06 2001-07-06 1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
PCT/EP2002/007597 WO2003004023A1 (fr) 2001-07-06 2002-07-06 Derives de 1-alkyl-2-aryl-benzimidazole, leur utilisation pour produire des medicaments, et preparations pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
JP2004530731A JP2004530731A (ja) 2004-10-07
JP2004530731A5 true JP2004530731A5 (fr) 2009-10-01

Family

ID=7692119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003510034A Pending JP2004530731A (ja) 2001-07-06 2002-07-06 １−アルキル−２−アリール−ベンズイミダゾール誘導体、医薬製剤の製造のためへのそれらの使用、及びそれらの誘導体を含む医薬製剤

Country Status (4)

Country Link
EP (1) EP1404321A1 (fr)
JP (1) JP2004530731A (fr)
DE (1) DE10134775A1 (fr)
WO (1) WO2003004023A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10207843A1 (de) * 2002-02-15 2003-09-04 Schering Ag Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen
AU2003257329C1 (en) * 2002-08-19 2010-07-22 Lorus Therapeutics Inc. 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
WO2004035549A1 (fr) 2002-10-17 2004-04-29 Amgen Inc. Derives de benzimidazoles et utilisation de ceux-ci en tant que ligands du recepteur vanilloide
JP5095216B2 (ja) 2003-11-14 2012-12-12 ローラス セラピューティクス インコーポレーテッド アリールイミダゾールおよびその抗癌剤としての使用
DE102004026590A1 (de) * 2004-06-01 2006-01-12 Siemens Ag Assistenzsystem für Kraftfahrzeuge
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
AU2006250809B2 (en) 2005-05-25 2011-05-12 Lorus Therapeutics Inc. 2-indolyl imidazo(4,5-D)phenanthroline derivatives and their use in the treatment of cancer
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
BRPI0919816A2 (pt) * 2008-09-26 2019-09-24 Eisai R&D Man Co Ltd uso compostos benzoxazólicos no tratamento de malária
EP2350032B1 (fr) * 2008-09-26 2016-05-25 Eisai R&D Management Co., Ltd. Composés benzoxazole et procédés d'utilisation
US20120263646A1 (en) * 2009-10-15 2012-10-18 Guerbet Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
WO2014153464A2 (fr) 2013-03-20 2014-09-25 Lorus Therapeutics Inc. Dérivés d'imidazo[4,5-d]phénanthroline 2-substitués et leur utilisation dans le traitement du cancer
EP3052102B1 (fr) 2013-10-04 2019-12-04 Aptose Biosciences Inc. Compositions pour le traitement de cancers
HUE051771T2 (hu) * 2015-12-15 2021-03-29 Univ Leland Stanford Junior Módszer a korral összefüggõ kognitív zavar és ideggyulladás megelõzésére és/vagy kezelésére
KR20200096914A (ko) 2017-10-30 2020-08-14 압토스 바이오사이언시스 인코포레이티드 암 치료용 아릴 이미다졸
MX2021001456A (es) * 2018-08-06 2021-05-27 Univ Leland Stanford Junior 2-arilbenzimidazoles como activadores de ppargc1a para tratar enfermedades neurodegenerativas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US5552426A (en) * 1994-04-29 1996-09-03 Eli Lilly And Company Methods for treating a physiological disorder associated with β-amyloid peptide
DK1246808T3 (da) * 2000-01-14 2011-12-05 Bayer Pharma AG 1,2-diarylbenzimidazoler til behandling af sygdomme, som er associeret med en mikroglia-aktivering

Similar Documents

Publication Publication Date Title
JP2004532269A5 (fr)
JP2004537984A5 (fr)
JP2006514019A5 (fr)
JP2004244619A5 (fr)
JP2004168997A5 (fr)
JP2003305787A5 (fr)
JP2003193065A5 (fr)
JP2005533836A5 (fr)
JP2003321523A5 (fr)
JP2004530731A5 (fr)
JP2006510481A5 (fr)
JP2004155888A5 (fr)
JP2005523387A5 (fr)
JP2004262980A5 (fr)
JP2004188303A5 (fr)
JP2005532980A5 (fr)
JP2004522835A5 (fr)
JP2003007517A5 (fr)
JP2004537572A5 (fr)
JP2004518010A5 (fr)
JP2005002267A5 (fr)
JP2003073772A5 (fr)
JP2003268293A5 (fr)
JP2005000126A5 (fr)
JP2003073555A5 (fr)